Status:
WITHDRAWN
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE:...
Detailed Description
OBJECTIVES: * To test preliminary data from node-positive oral squamous cell carcinoma (OSCC) signatures for their ability to predict lymph-positive primaries using a cohort of OSCC tumors. * To perf...
Eligibility Criteria
Inclusion
- Have a primary tumor specimen banked by the American College of Surgeons Oncology Group (ACOSOG) as part of clinical trial ACOSOG-Z0360
- \* All tumor specimens are squamous cell carcinomas of the tongue, floor of the mouth, or gingiva
- All patients have undergone neck dissections \* Pathologically confirmed nodal stage (negative or positive)
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00899704
Start Date
March 1 2008
End Date
March 1 2008
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-4283